Tango Therapeutics, Inc. - 08 Dec 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role: Director
Signature: /s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol: BPMC
Transactions as of: 08 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Dec 2021, 15:25:29 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BPMC	Common Stock	Award	$0	+3,400		$0.000000	3,400	08 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BPMC	Stock Option (Right to Buy)	Award	$0	+7,000		$0.000000	7,000	08 Dec 2021	Common Stock	7,000	$98.72	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction involved the Reporting Person's receipt of a grant of 3,400 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
F2	This option vests with respect to 1/36th of the shares underlying the option on January 8, 2022 and as to an additional 1/36th of the shares underlying the option each month thereafter.